On September 22, 2025, a lawsuit was filed in Delaware Court of Chancery on behalf of all former public stockholders of RCM, Inc. ("RI" or the "Company") as of the closing of the transaction with affiliates of TowerBrook Capital Partners L.P. ("TowerBrook"), Ascension Health Alliance ("Ascension"), and Clayton Dubilier & Rice ("CD&R") to take the Company private for $14.30 per share in cash (the "Take-Private Acquisition").
We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.